SCHEMBL22650188

SCHEMBL22650188

CC(C)(C)Cc1ccc(C(=O)O)c(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 0.64
▸ L3MBTL1 Q9Y468 1/20 0.64
▸ DNASE1L3 Q13609 1/20 0.57
▸ PRMT1 Q99873 1/20 0.57
▸ MEN1 O00255 2/20 0.56
▸ POLB P06746 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ ALPL P05186 1/20 0.56
▸ ALPI P09923 1/20 0.56
▸ ALPG P10696 1/20 0.56
▸ ATM Q13315 1/20 0.54
▸ PLEC Q15149 1/20 0.54
▸ CA9 Q16790 11/20 0.50
▸ CA1 P00915 9/20 0.50
▸ CA2 P00918 9/20 0.50
▸ CA12 O43570 4/20 0.50
▸ CA14 Q9ULX7 3/20 0.50
▸ CA7 P43166 3/20 0.49
▸ ESR1 P03372 1/20 0.49
▸ ALB P02768 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24594128 0.89 USP2 (0.64) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL20256560 0.89 USP2 (0.59) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL18754815 0.87 USP2 (0.62) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL22107769 0.87 USP2 (0.64) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL18211419 0.86 USP2 (0.61) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL23158776 0.86 USP2 (0.56) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL19370241 0.85 USP2 (0.64) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL12045940 0.83 USP2 (0.68) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL13384808 0.83 USP2 (0.85) USP2L3MBTL1DNASE1L3PRMT1MEN1
SCHEMBL13401323 0.83 USP2 (0.62) USP2L3MBTL1DNASE1L3PRMT1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200353094-A1 PHOSPHOALKYL RIBOSE POLYMERS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS Sony Group Corporation (JP) 2020-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200353094-A1 PHOSPHOALKYL RIBOSE POLYMERS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS PARP1, PARP11, PHOSPHO1 USP2 2969/4885L3MBTL1 68/4885DNASE1L3 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback